Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

US9005632B2 · kind B2 · utility

Assignee

• Takeda Vaccines, Inc. · US

Inventors

• Dan T. Stinchcomb · Boulder, US
• Jorge E. Osorio · Mount Horeb, US
• Timothy D. Powell · Fort Collins, US
• Jeremy C. Jones · Madison, US
• Joseph N. Brewoo · Madison, US

Key dates

• Filing date: Jul 20, 2012
• Grant date: Apr 14, 2015
• Expiry date: Jul 20, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2760/16134
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions having two or more influenza gene segments. In other embodiments, vaccine compositions are reported of use in a subject.